We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Cormedix Inc
7 own
19 watching
Current Price
$4.48
$0.04
(0.9%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
184.61M
52-Week High
8.025
52-Week Low
2.645
Average Volume
0.31M
Dividend Yield
--
P/E Ratio
--
Market Capitalization184.61M52-Week High8.02552-Week Low2.645Average Volume0.31MDividend Yield--P/E Ratio--What does the Cormedix Inc do?
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Read More
How much money does Cormedix Inc make?
News & Events about Cormedix Inc.
Globe Newswire
17days ago
BERKELEY HEIGHTS, N.J., Jan. 17, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced the following promotions ...
Globe Newswire
1month ago
BERKELEY HEIGHTS, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced the abstract publication ...
Globe Newswire
2 months ago
NEW YORK, Nov. 19, 2022 (GLOBE NEWSWIRE) -- Okta, Inc. (NASDAQ: OKTA) Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Okta alleging that Defendants made materially false and misleading statements regarding the Companys business, operations, and ...
Globe Newswire
2 months ago
BERKELEY HEIGHTS, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that the Center for ...
Globe Newswire
4 months ago
BERKELEY HEIGHTS, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that management will be ...
Frequently Asked Questions
Frequently Asked Questions
What is Cormedix Inc share price today?
Can Indians buy Cormedix Inc shares?
How can I buy Cormedix Inc shares from India?
Can Fractional shares of Cormedix Inc be purchased?
What are the documents required to start investing in Cormedix Inc stocks?
What is today’s traded volume of Cormedix Inc?
What is today’s market capitalisation of Cormedix Inc?
What is the 52-Week High and Low Range of Cormedix Inc?
What percentage is Cormedix Inc down from its 52-Week High?
What percentage is Cormedix Inc up from its 52-Week Low?
Current Price
$4.48
$0.04
(0.9%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.